Skip to content
Privacy

Privacy notice

A layered privacy notice for the current Veridose product and its still-open legal review points.

Prepared for legal review. This notice explains current product intent and the limits of what is published until processing purposes, lawful bases, retention and vendor mapping are approved.

Privacy in one minute

Veridose may handle sensitive information, including health or disability related information.

Most sensitive data starts private and we try to collect only what is necessary for the task at hand.

Verification is designed to avoid unnecessary document sharing and users can manage sharing where the product supports it.

Access is logged where applicable, health data is not sold for advertising and users have data-protection rights.

Who is responsible for your information?

Trent End Ventures Ltd trading as Veridose is the current operating entity for this product.

The exact controller, processor and joint-controller position for each workflow is subject to completed legal-role analysis and should not be assumed globally.

Information we may collect

The categories below are used only where the product actually supports the relevant workflow.

  • Account information
  • Authentication and security information
  • Profile information
  • Dependant information
  • Relationship and authority information
  • Medication information
  • Prescription information
  • Disability and accessibility information
  • Uploaded evidence
  • Verification decisions
  • Organisation relationships
  • Venue and school interactions
  • Training history
  • Certificate information
  • Sharing permissions
  • Audit and access events
  • Support messages
  • Technical and security logs
  • Payment or order information if payments exist
  • Communications preferences
  • Cookie and analytics information if enabled

Special-category information

Health, disability and similar sensitive information receives additional protection.

The platform is designed to keep raw evidence separate from a verification outcome, and to avoid showing more than the scenario requires.

Why information is used

The purpose registry below is the source for public wording. Any purpose that has not been reviewed remains a production blocker rather than being described as approved.

Account creation

Set up and administer an account holder profile.

legal review required

Create and maintain a Veridose account.

Authentication

Sign users in, protect sessions and detect abuse.

legal review required

Authenticate users and protect access.

Medication profile storage

Keep private medication profile data available for authorised use.

legal review required

Store user-provided medication profile information.

Verification review

Determine whether the specific claim is verified.

legal review required

Review evidence and decide verification outcomes.

Sharing authorisation

Let users control what is shared and with whom.

legal review required

Record granular sharing permissions and expiry.

Support

Respond to service, account and accessibility requests.

researching

Handle support requests and accessibility requests.

Direct marketing

Communicate offers or product updates where allowed.

legal review required

Send product updates where permission exists.

Lawful basis

A structured internal basis register exists for the product, but public wording should not invent a lawful basis that has not been reviewed.

Until a purpose reaches approved legal review status, it is flagged as a blocker rather than published as settled legal wording.

  • No purpose currently has approved public lawful-basis wording.

Article 9 conditions

The application does not claim a blanket Article 9 condition for all sensitive data.

Where a special-category condition applies, it must be tied to the specific processing purpose and approved in the registry before public wording is published.

Sharing

We share different categories of information with different recipients depending on the purpose and the user action involved.

Processors, organisations, verification recipients and support providers do not all receive the same information.

Processors

The subprocessors page should list the active vendors once they are confirmed in the vendor register and approved for public disclosure.

At present the product should not assume more than the code and environment actually show.

International transfers

International transfer wording should only describe actual transfers after they have been mapped and reviewed.

If special-category information is sent outside the UK, a documented transfer assessment is required where the law or policy requires it.

Retention

Retention must be handled by category and purpose, not by guesswork.

A human-readable retention overview should explain the current policy before production use.

Security

Security controls are layered at a high level and avoid publishing exploit-enabling detail.

Sensitive access is intended to be logged and constrained by role, purpose and review state.

Children and dependants

Child and dependant data receives higher protection and the context should remain clear when one account manages another person.

Separate children and families notices are needed for the layered product model.

Your rights

Where the law applies, people can ask for information, access, rectification, erasure, restriction, portability, objection, withdrawal of consent and review of automated decision-making.

Not all rights are absolute, and the effect of a request depends on the law and the records involved.

Complaints

People should be able to raise privacy or service complaints through Veridose and, where applicable, complain to the ICO.

The app should not discourage external complaints where the law gives that option.

Current review state

This privacy notice remains a working compliance draft until the legal register is completed and reviewed.

  • Account creation: legal review required
  • Authentication: legal review required
  • Medication profile storage: legal review required
  • Verification review: legal review required
  • Sharing authorisation: legal review required
  • Support: researching
  • Direct marketing: legal review required